(Press-News.org) New Rochelle, NY, June 20, 2013—At least half of all cases of deafness that develop from birth through infancy in developed countries have a genetic basis, as do many cases of later onset progressive hearing loss. To date, at least 1,000 mutations occurring in 64 genes in the human genome have been linked to hearing loss. Next-generation DNA sequencing technologies are enabling the identification of these deafness-causing genetic variants, as described in a Review article in Genetic Testing and Molecular Biomarkers, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available on the Genetic Testing and Molecular Biomarkers website.
In "Next-Generation Sequencing in Genetic Hearing Loss," Denise Yan and Xue Zhong Liu, University of Miami (Florida), and Mustafa Tekin and Susan Blanton, University of Miami Miller School of Medicine, review the advances in high-throughput, massively parallel DNA sequencing that amplify and repeatedly sequence only specific regions of the human genome in which genes linked to deafness are likely to be found. This strategy, known as "targeted resequencing," allows researchers to find disease-related gene mutations much more quickly than searching through the entire genome. To date at least 1,000 DNA variants at more than 130 sites in the human genome have been identified that can cause hearing loss not associated with other symptoms or syndromes.
"Over the next decade, most of the variant genes responsible for deafness will be identified and such knowledge will lead to the development of practical treatments," conclude the authors.
"Knowledge of the genetic lesions underlying deafness will greatly assist development of targeted therapy," says Kenneth I. Berns, MD, PhD, Editor-in-Chief of Genetic Testing and Molecular Biomarkers, and Director of the University of Florida's Genetics Institute, College of Medicine, Gainesville, FL.
INFORMATION:
About the Journal
Genetic Testing and Molecular Biomarkers is an authoritative peer-reviewed journal published 12 times per year in print and online that reports on all aspects of genetic testing, including molecular and biochemical based tests and varied clinical situations; ethical, legal, social, and economic aspects of genetic testing; and issues concerning effective genetic counseling. Tables of content and a free sample issue may be viewed on the Genetic Testing and Molecular Biomarkers website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Human Gene Therapy and OMICS: A Journal of Integrative Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry's most widely read publication worldwide. A complete list of the firm's 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.
Mary Ann Liebert, Inc.
140 Huguenot St.,
New Rochelle, NY 10801-5215
http://www.liebertpub.com
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101
Goal of identifying nearly all genetic causes of deafness is within reach
2013-06-20
ELSE PRESS RELEASES FROM THIS DATE:
African-Americans on Medicaid are far less likely to receive living kidney transplants
2013-06-20
WINSTON-SALEM, N.C. – June 20, 2013 – African-Americans with Medicaid as their primary insurance were less likely to receive a living kidney transplant (LKT) than patients with private insurance, according to a new study by researchers at Wake Forest Baptist Medical Center.
The study is published on the Early View online edition of Clinical Transplantation.
"Living kidney transplantation is the optimal treatment for patients with end-stage renal disease, offering the best quality of life and longest survival," said Amber Reeves-Daniel, D.O., assistant professor of nephrology ...
Particle accelerator that can fit on a tabletop opens new chapter for science research
2013-06-20
AUSTIN, Texas — Physicists at The University of Texas at Austin have built a tabletop particle accelerator that can generate energies and speeds previously reached only by major facilities that are hundreds of meters long and cost hundreds of millions of dollars to build.
"We have accelerated about half a billion electrons to 2 gigaelectronvolts over a distance of about 1 inch," said Mike Downer, professor of physics in the College of Natural Sciences. "Until now that degree of energy and focus has required a conventional accelerator that stretches more than the length ...
Herding cancer cells to their death
2013-06-20
June 20, 2013, New York, NY and Oxford, UK — An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors. This cellular heterogeneity is what makes advanced tumors so difficult to treat. Publishing their findings in today's online issue of Cancer Cell, an international team of scientists led jointly by Professors Colin Goding from the Ludwig Institute for Cancer Research who is based at the University of Oxford and José Neptuno ...
Changing ocean temperatures, circulation patterns affecting young Atlantic cod food supply
2013-06-20
Changing ocean water temperatures and circulation patterns have profoundly affected key Northeast U.S. Continental Shelf zooplankton species in recent decades, and may be influencing the recovery of Atlantic cod and other fish stocks in the region.
NOAA researcher Kevin Friedland and colleagues looked at the distribution and abundance of important zooplankton species, sea surface water temperatures, and cod abundance. They found that zooplankton species critical for the survival of Atlantic cod larvae have declined in abundance in the same areas where Atlantic cod stocks ...
Critical seconds saved during brain aneurysm procedure with pre-surgery rehearsal
2013-06-20
VIDEO:
Surgical Theater aims to allow each and every neurosurgeon the ability to "Pre-Live the Future. " The Surgical Rehearsal Platform (SRP) supports a neurosurgeon's goal of providing patients with the best...
Click here for more information.
Surgical Theater's Surgical Rehearsal Platform™ (SRP) provided neurosurgeons the opportunity to rehearse a complicated cerebral case before entering the operating room, saving the surgical team critical seconds on a time-sensitive ...
Why jumping genes don't send us into meltdown
2013-06-20
The study reveals for the first time how the movement and duplication of segments of DNA known as transposons, is regulated. This prevents a genomic meltdown, and instead enables transposons to live in harmony with their hosts — including humans.
Transposons were discovered in the 1940s by Barbara McClintock, who was rewarded in 1983 with the Nobel Prize for Physiology or Medicine. Ancient relics of these 'jumping genes', as they are sometimes called, make up 50 per cent of the DNA in humans. They are characterised as 'jumping' because they can change their position within ...
Elevated gluten antibodies found in children with autism but no link to celiac disease
2013-06-20
NEW YORK, NY (June 20, 2013)—Researchers have found elevated antibodies to gluten proteins of wheat in children with autism in comparison to those without autism. The results also indicated an association between the elevated antibodies and the presence of gastrointestinal symptoms in the affected children. They did not find any connection, however, between the elevated antibodies and celiac disease, an autoimmune disorder known to be triggered by gluten. The results were e-published in the journal PLOS ONE.
Gluten, a group of more than 70 proteins in wheat and related ...
Chlamydia promotes gene mutations
2013-06-20
This news release is available in German. Chlamydia trachomatis is a human pathogen that is the leading cause of bacterial sexually transmitted disease worldwide with more than 90 million new cases of genital infections occurring each year. About 70 percent of women infected with Chlamydia remain asymptomatic and these bacteria can establish chronic infections for months, or even years. Even when it causes no symptoms, Chlamydia can damage a woman's reproductive organs. In addition, standard antibacterial drugs are proving increasingly ineffective in complete eradication, ...
Hubble spots galaxies in close encounter
2013-06-20
Just below the centre of this image is the blue, twisted form of galaxy NGC 2936, one of the two interacting galaxies that form Arp 142 in the constellation of Hydra. Nicknamed "the Penguin" or "the Porpoise" by amateur astronomers, NGC 2936 used to be a standard spiral galaxy before being torn apart by the gravity of its cosmic companion.
The remnants of its spiral structure can still be seen — the former galactic bulge now forms the "eye" of the penguin, around which it is still possible to see where the galaxy's pinwheeling arms once were. These disrupted arms now ...
Berkeley Lab confirms thirdhand smoke causes DNA damage
2013-06-20
A study led by researchers from Lawrence Berkeley National Laboratory has found for the first time that thirdhand smoke—the noxious residue that clings to virtually all surfaces long after the secondhand smoke from a cigarette has cleared out—causes significant genetic damage in human cells.
Furthermore, the study also found that chronic exposure is worse than acute exposure, with the chemical compounds in samples exposed to chronic thirdhand smoke existing in higher concentrations and causing more DNA damage than samples exposed to acute thirdhand smoke, suggesting that ...